Sale of 100% of Grupo Anbioton to Elfa Medicamentos
Exclusive financial advisor to Grupo Anbioton
May 2021• In May 2021, Elfa Medicamentos S.A. (“Elfa”) completed the acquisition of 100% of Anbioton Importadora Ltda. and Natbio Importadora Ltda. (“Grupo Anbioton”) for R$65.2 million
– Additional purchase price contingent to the achievement of certain financial targets
– This transactions is aligned with Elfa’ strategy to increase its presence in the Southeast region of Brazil
• Founded in 2009, Grupo Anbioton is a pharmaceutical distributor to institutional, non-retail healthcare facilities
– Supplier to more than 1,400 private hospitals and 200 public entities in Brazil
• Elfa is a leading pharmaceutical distributor in Brazil focused on the distribution of specialty medicines, generic and branded generic drugs, and hospital materials and high value-added solutions
– Since Patria acquired Elfa in 2014, the company has been leading the consolidation of the distribution sector in Brazil via the acquisition of several regional distributors